Lymphadenopathy

  • What is it:
    • Lymphadenopathy refers to the enlargement of lymph nodes due to various causes, such as infections, inflammation, or malignancy. It can be localized (involving a specific group of nodes) or generalized (involving multiple groups).
  • Etymology:
    • “Lymph” is derived from the Latin “lympha,” meaning clear water, referring to the lymph fluid circulating through the lymphatic system. “Adenopathy” comes from the Greek “adenos” (gland) and “pathos” (suffering), meaning a disease of the glands, referring to the lymph nodes in this context.
  • How does it appear on each relevant imaging modality:
    • Chest X-ray:
      • Parts: Lymphadenopathy may be seen as enlarged lymph nodes, particularly in the hilar or mediastinal regions.
      • Size: Enlarged lymph nodes are often visible on lateral views when they exceed a certain size, usually greater than 1 cm in the mediastinum.
      • Shape: Nodes can appear round, oval, or irregular in shape.
      • Position: Typically found in the hilum or mediastinum; cervical or supraclavicular lymphadenopathy may also be visible.
      • Character:
        • Sometimes larger calcifications can be seen on a CXR
    • CT Scan:
      • Parts: Lymph nodes appear as rounded or oval soft tissue masses,
      • Size: Enlarged nodes are usually defined as being greater than 1 cm in diameter in the short axis. Nodes greater than 1 cm are more likely to be pathological,
      • Some reports suggest that the subcarinal node should be greater than 1.2cms to be considered pathological
      • Shape:
        • Most are usual round oval
      • Position:
        • Can be visualized in the mediastinum, hilar, or cervical regions.
      • Character: Pathological
        • Homogeneous soft tissue density
        • Calcification: Lymph nodes can exhibit calcification, which is important in determining etiology:
          • Central calcification:
            • Often seen in benign conditions such as tuberculosis or histoplasmosis.
          • Eggshell calcification: A distinctive finding in
            • sarcoidosis
            • silicosis
          • Psammomatous  calcification:
            • malignancy.
              • papillary thyroid cancer
              • mucin secreting metastases
            • sarcoidosis sometimes early calcification is “sand-like”
      • Pathological vs Non-pathological distinction:
        • Pathological lymphadenopathy is typically characterized by nodes greater than 1 cm in size,
        • Non-pathological lymphadenopathy,
          • normal in size or
          • enlarged
    • MRI:
      • Not usually used for evaluation of lymph nodes
    • PET-CT:
      • Role:
        • PET-CT is
          • crucial for assessing the
          • metabolic activity of enlarged lymph nodes, particularly for malignancy.
        • It helps distinguish between pathological and non-pathological nodes by detecting increased glucose metabolism,
        • typically seen in malignant nodes
        • or active inflammatory conditions or infections.
        • The size of the node usually has to be larger than 7mm but if there is a significant hypermetabolic level it will show activity even if smaller than 7mm
  • Differential diagnosis enlarged lymph nodes:
    • Infection: Tuberculosis, bacterial infections (e.g., pneumonia, abscess), viral infections (e.g., Epstein-Barr virus, HIV).
    • Inflammation: Sarcoidosis, rheumatoid arthritis, or other autoimmune diseases.
    • Neoplasm: Lymphoma, metastatic cancer, primary lung cancer, or other malignancies.
    • Metabolic: Conditions like amyloidosis or Gaucher’s disease that may cause non-malignant lymphadenopathy.
  • Recommendations:
    • Next diagnostic steps:
      • Further imaging with CT or MRI for detailed evaluation of the size, shape, and characteristics of enlarged lymph nodes.
      • Biopsy may be needed for histological examination, particularly if malignancy or infection is suspected.
      • Laboratory testing: Blood tests to evaluate for infections (e.g., CBC, tuberculin skin test), autoimmune markers, or cancer screening.